{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:13:34Z","timestamp":1792707214804,"version":"4.5.0"},"reference-count":59,"publisher":"American Association for Cancer Research (AACR)","issue":"22","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Isocitrate dehydrogenase 1 (IDH1) is mutated in various types of human cancer to IDH1R132H, a structural alteration that leads to catalysis of \u03b1-ketoglutarate to the oncometabolite D-2-hydroxyglutarate. In this study, we present evidence that small-molecule inhibitors of IDH1R132H that are being developed for cancer therapy may pose risks with coadministration of radiotherapy. Cancer cells heterozygous for the IDH1R132H mutation exhibited less IDH-mediated production of NADPH, such that after exposure to ionizing radiation (IR), there were higher levels of reactive oxygen species, DNA double-strand breaks, and cell death compared with IDH1 wild-type cells. These effects were reversed by the IDH1R132H inhibitor AGI-5198. Exposure of IDH1 wild-type cells to D-2-hydroxyglutarate was sufficient to reduce IDH-mediated NADPH production and increase IR sensitivity. Mechanistic investigations revealed that the radiosensitivity of heterozygous cells was independent of the well-described DNA hypermethylation phenotype in IDH1-mutated cancers. Thus, our results argue that altered oxidative stress responses are a plausible mechanism to understand the radiosensitivity of IDH1-mutated cancer cells. Further, they offer an explanation for the relatively longer survival of patients with IDH1-mutated tumors, and they imply that administration of IDH1R132H inhibitors in these patients may limit irradiation efficacy in this setting. Cancer Res; 75(22); 4790\u2013802. \u00a92015 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-14-3603","type":"journal-article","created":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T22:34:59Z","timestamp":1442010899000},"page":"4790-4802","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":144,"title":["Radioprotection of\n                    <i>IDH1<\/i>\n                    -Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198"],"prefix":"10.1158","volume":"75","author":[{"given":"Remco J.","family":"Molenaar","sequence":"first","affiliation":[{"name":"1Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Botman","sequence":"additional","affiliation":[{"name":"1Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrthe A.","family":"Smits","sequence":"additional","affiliation":[{"name":"1Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vashendriya V.","family":"Hira","sequence":"additional","affiliation":[{"name":"1Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne A.","family":"van Lith","sequence":"additional","affiliation":[{"name":"2Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Stap","sequence":"additional","affiliation":[{"name":"1Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Henneman","sequence":"additional","affiliation":[{"name":"3Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Khurshed","sequence":"additional","affiliation":[{"name":"1Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krissie","family":"Lenting","sequence":"additional","affiliation":[{"name":"2Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri N.","family":"Mul","sequence":"additional","affiliation":[{"name":"3Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysia","family":"Dimitrakopoulou","sequence":"additional","affiliation":[{"name":"1Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis M.","family":"van Drunen","sequence":"additional","affiliation":[{"name":"4Department of Otorhinolaryngology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron A.","family":"Hoebe","sequence":"additional","affiliation":[{"name":"1Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Radivoyevitch","sequence":"additional","affiliation":[{"name":"5Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna W.","family":"Wilmink","sequence":"additional","affiliation":[{"name":"6Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[{"name":"7Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Peter","family":"Vandertop","sequence":"additional","affiliation":[{"name":"8Department of Neurosurgery, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands."},{"name":"9Department of Neurosurgery, VU Medical Center, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.","family":"Leenders","sequence":"additional","affiliation":[{"name":"2Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fonnet E.","family":"Bleeker","sequence":"additional","affiliation":[{"name":"3Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis J.","family":"van Noorden","sequence":"additional","affiliation":[{"name":"1Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2015,11,15]]},"reference":[{"key":"2022061706363469000_bib1","first-page":"326","article-title":"The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation","volume":"1846","author":"Molenaar","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2022061706363469000_bib2","first-page":"66","article-title":"Glutamate as chemotactic fuel for diffuse glioma cells: are they glutamate suckers","volume":"1846","author":"van Lith","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2022061706363469000_bib3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N Engl J Med"},{"key":"2022061706363469000_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1126\/science.1170944","article-title":"Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha","volume":"324","author":"Zhao","year":"2009","journal-title":"Science"},{"key":"2022061706363469000_bib5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-010-0645-6","article-title":"The prognostic IDH1(R132) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma","volume":"119","author":"Bleeker","year":"2010","journal-title":"Acta Neuropathol"},{"key":"2022061706363469000_bib6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"key":"2022061706363469000_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/embor.2011.43","article-title":"The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases","volume":"12","author":"Chowdhury","year":"2011","journal-title":"EMBO Rep"},{"key":"2022061706363469000_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"key":"2022061706363469000_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature10866","article-title":"IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype","volume":"483","author":"Turcan","year":"2012","journal-title":"Nature"},{"key":"2022061706363469000_bib10","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"2022061706363469000_bib11","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/neuonc\/nou005","article-title":"The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone","volume":"16","author":"Molenaar","year":"2014","journal-title":"Neuro Oncol"},{"key":"2022061706363469000_bib12","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1038\/onc.2012.315","article-title":"Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas","volume":"32","author":"Wang","year":"2013","journal-title":"Oncogene"},{"key":"2022061706363469000_bib13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1634\/theoncologist.2009-0218","article-title":"IDH1 gene mutations: a new paradigm in glioma prognosis and therapy","volume":"15","author":"Labussiere","year":"2010","journal-title":"Oncologist"},{"key":"2022061706363469000_bib14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1084\/jem.20100523","article-title":"Metabolism and the leukemic stem cell","volume":"207","author":"Abdel-Wahab","year":"2010","journal-title":"J Exp Med"},{"key":"2022061706363469000_bib15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s13277-014-2644-z","article-title":"Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation","volume":"36","author":"Shi","year":"2015","journal-title":"Tumour Biol"},{"key":"2022061706363469000_bib16","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s10495-013-0877-8","article-title":"Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell death","volume":"18","author":"Mohrenz","year":"2013","journal-title":"Apoptosis"},{"key":"2022061706363469000_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/neuonc\/nos261","article-title":"Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation","volume":"15","author":"Li","year":"2013","journal-title":"Neuro Oncol"},{"key":"2022061706363469000_bib18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1200\/JCO.2013.49.3726","article-title":"Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH","volume":"32","author":"Cairncross","year":"2014","journal-title":"J Clin Oncol"},{"key":"2022061706363469000_bib19","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/neuonc\/not198","article-title":"Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry","volume":"16","author":"Tran","year":"2014","journal-title":"Neuro Oncol"},{"key":"2022061706363469000_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11060-011-0793-0","article-title":"Recent advances in the molecular understanding of glioblastoma","volume":"108","author":"Bleeker","year":"2012","journal-title":"J Neurooncol"},{"key":"2022061706363469000_bib21","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/ng.1004","article-title":"Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome","volume":"43","author":"Pansuriya","year":"2011","journal-title":"Nat Genet"},{"key":"2022061706363469000_bib22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature13441","article-title":"Mutant IDH inhibits HNF-4alpha to block hepatocyte differentiation and promote biliary cancer","volume":"513","author":"Saha","year":"2014","journal-title":"Nature"},{"key":"2022061706363469000_bib23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.1236062","article-title":"An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells","volume":"340","author":"Rohle","year":"2013","journal-title":"Science"},{"key":"2022061706363469000_bib24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.1234769","article-title":"Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation","volume":"340","author":"Wang","year":"2013","journal-title":"Science"},{"key":"2022061706363469000_bib25","doi-asserted-by":"crossref","first-page":"13717","DOI":"10.1074\/jbc.M113.511030","article-title":"Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate dehydrogenase IDH1","volume":"289","author":"Davis","year":"2014","journal-title":"J Biol Chem"},{"key":"2022061706363469000_bib26","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1182\/blood-2013-03-491571","article-title":"Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML","volume":"122","author":"Chaturvedi","year":"2013","journal-title":"Blood"},{"key":"2022061706363469000_bib27","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1074\/jbc.M114.608497","article-title":"Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by an allosteric small molecule","volume":"290","author":"Deng","year":"2015","journal-title":"J Biol Chem"},{"key":"2022061706363469000_bib28","first-page":"84","article-title":"Development of human gene reporter cell lines using rAAV mediated homologous recombination","volume":"9","author":"Fernandez","year":"2007","journal-title":"Biol Proced Online"},{"key":"2022061706363469000_bib29","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1158\/0008-5472.CAN-14-0008","article-title":"IDH1 R132H mutation generates a distinct phospholipid metabolite profile in glioma","volume":"74","author":"Esmaeili","year":"2014","journal-title":"Cancer Res"},{"key":"2022061706363469000_bib30","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-009-0595-z","article-title":"Monoclonal antibody specific for IDH1 R132H mutation","volume":"118","author":"Capper","year":"2009","journal-title":"Acta Neuropathol"},{"key":"2022061706363469000_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.proghi.2012.09.001","article-title":"Image cytometry: protocols for 2D and 3D quantification in microscopic images","volume":"47","author":"Chieco","year":"2013","journal-title":"Prog Histochem Cytochem"},{"key":"2022061706363469000_bib32","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.neuint.2007.03.010","article-title":"Responses of the mitochondrial alpha-ketoglutarate dehydrogenase complex to thiamine deficiency may contribute to regional selective vulnerability","volume":"50","author":"Shi","year":"2007","journal-title":"Neurochem Int"},{"key":"2022061706363469000_bib33","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat Protoc"},{"key":"2022061706363469000_bib34","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"2022061706363469000_bib35","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","article-title":"Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays","volume":"30","author":"Aryee","year":"2014","journal-title":"Bioinformatics"},{"key":"2022061706363469000_bib36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.1088845","article-title":"Dynamics of DNA double-strand breaks revealed by clustering of damaged chromosome domains","volume":"303","author":"Aten","year":"2004","journal-title":"Science"},{"key":"2022061706363469000_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-013-1194-6","article-title":"Autophagy and oxidative stress in gliomas with IDH1 mutations","volume":"127","author":"Gilbert","year":"2014","journal-title":"Acta Neuropathol"},{"key":"2022061706363469000_bib38","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1046\/j.1460-9568.2003.02639.x","article-title":"D-2-hydroxyglutaric acid induces oxidative stress in cerebral cortex of young rats","volume":"17","author":"Latini","year":"2003","journal-title":"Eur J Neurosci"},{"key":"2022061706363469000_bib39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1460-9568.2002.02055.x","article-title":"NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d-2-hydroxyglutaric aciduria","volume":"16","author":"Kolker","year":"2002","journal-title":"Eur J Neurosci"},{"key":"2022061706363469000_bib40","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1182\/blood-2014-05-577940","article-title":"Genetic dissection of leukemia-associated IDH1 and IDH2 mutants and D-2-hydroxyglutarate in Drosophila","volume":"125","author":"Reitman","year":"2015","journal-title":"Blood"},{"key":"2022061706363469000_bib41","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature10898","article-title":"Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation","volume":"483","author":"Koivunen","year":"2012","journal-title":"Nature"},{"key":"2022061706363469000_bib42","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1158\/0008-5472.CAN-14-0772-T","article-title":"IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism","volume":"74","author":"Grassian","year":"2014","journal-title":"Cancer Res"},{"key":"2022061706363469000_bib43","doi-asserted-by":"crossref","first-page":"12279","DOI":"10.18632\/oncotarget.3733","article-title":"Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype","volume":"6","author":"Cuyas","year":"2015","journal-title":"Oncotarget"},{"key":"2022061706363469000_bib44","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ccell.2014.10.001","article-title":"Is reliance on mitochondrial respiration a \u201cchink in the armor\u201d of therapy-resistant cancer?","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell"},{"key":"2022061706363469000_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2015.91","article-title":"Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms","author":"Molenaar","year":"2015  3","journal-title":"Leukemia"},{"key":"2022061706363469000_bib46","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1369\/jhc.2009.953828","article-title":"Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women","volume":"57","author":"Peters","year":"2009","journal-title":"J Histochem Cytochem"},{"key":"2022061706363469000_bib47","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Cancer Genome Atlas N","year":"2012","journal-title":"Nature"},{"key":"2022061706363469000_bib48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","article-title":"The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate","volume":"17","author":"Ward","year":"2010","journal-title":"Cancer Cell"},{"key":"2022061706363469000_bib49","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/cr.2010.145","article-title":"Molecular mechanisms of \u201coff-on switch\u201d of activities of human IDH1 by tumor-associated mutation R132H","volume":"20","author":"Yang","year":"2010","journal-title":"Cell Res"},{"key":"2022061706363469000_bib50","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm.3788","article-title":"Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia","volume":"21","author":"Chan","year":"2015","journal-title":"Nat Med"},{"key":"2022061706363469000_bib51","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10545-012-9462-5","article-title":"Progress in understanding 2-hydroxyglutaric acidurias","volume":"35","author":"Kranendijk","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"2022061706363469000_bib52","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1101\/gad.198200.112","article-title":"D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function","volume":"26","author":"Sasaki","year":"2012","journal-title":"Genes Dev"},{"key":"2022061706363469000_bib53","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature13387","article-title":"A vaccine targeting mutant IDH1 induces antitumour immunity","volume":"512","author":"Schumacher","year":"2014","journal-title":"Nature"},{"key":"2022061706363469000_bib54","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0140-6736(14)61485-9","article-title":"Type 2 diabetes and cancer as redox diseases","volume":"384","author":"Molenaar","year":"2014","journal-title":"Lancet"},{"key":"2022061706363469000_bib55","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/neuonc\/nou152","article-title":"Tumor cells in search for glutamate: an alternative explanation for increased invasiveness of IDH1 mutant gliomas","volume":"16","author":"van Lith","year":"2014","journal-title":"Neuro Oncol"},{"key":"2022061706363469000_bib56","doi-asserted-by":"crossref","first-page":"14217","DOI":"10.1073\/pnas.1409653111","article-title":"Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma","volume":"111","author":"Chen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706363469000_bib57","doi-asserted-by":"crossref","first-page":"23318","DOI":"10.1074\/jbc.M114.575183","article-title":"Cancer-associated isocitrate dehydrogenase 1 (IDH1) R132H mutation and d-2-hydroxyglutarate stimulate glutamine metabolism under hypoxia","volume":"289","author":"Reitman","year":"2014","journal-title":"J Biol Chem"},{"key":"2022061706363469000_bib58","doi-asserted-by":"crossref","first-page":"8981","DOI":"10.1158\/0008-5472.CAN-10-1666","article-title":"Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1","volume":"70","author":"Seltzer","year":"2010","journal-title":"Cancer Res"},{"key":"2022061706363469000_bib59","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1158\/2159-8290.CD-13-0572","article-title":"A high-throughput fluorimetric assay for 2-hydroxyglutarate identifies Zaprinast as a glutaminase inhibitor","volume":"4","author":"Elhammali","year":"2014","journal-title":"Cancer Discov"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/75\/22\/4790\/2937251\/4790.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/75\/22\/4790\/2937251\/4790.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T16:09:59Z","timestamp":1655482199000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/75\/22\/4790\/662322\/Radioprotection-of-IDH1-Mutated-Cancer-Cells-by"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,15]]},"references-count":59,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2015,11,15]]},"published-print":{"date-parts":[[2015,11,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-14-3603","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22412271.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22412268","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22412277","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22412268.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6508407","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22412265.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22412283.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22412277.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22412280.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22412274.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22412265","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6508407.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22412274","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22412271","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22412283","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22412280","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,15]]}}}